Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study - Takeaways - MDSpire

Prognostic Evaluation Using Nutrition-Inflammation Biomarkers from Routine Blood Tests in Metastatic Breast Cancer: A Boruta Algorithm-Optimized Feature Selection Study

  • By

  • Nong, Wen-xiong

  • Huang, Sheng-kai

  • Zhang, Wenhai

  • Tan, Yang

  • Wu, Zhi-dong

  • Liang, Wan-wang

  • Wu, Rui-zheng

  • May 13, 2026

  • 0 min

Share

  • 1

    The study evaluated 17 nutrition and inflammation indices from blood tests in 163 metastatic breast cancer patients.

  • 2

    MLR, SIRI, ALI, AGR, and PA were identified as independent predictors of overall survival in metastatic breast cancer.

  • 3

    Patients with higher MLR and SIRI had significantly increased risks of death, while higher ALI, AGR, and PA correlated with reduced mortality risk.

  • 4

    Inflammation indices were better for short-term outcomes, while nutrition indices were more predictive of medium-to-long-term survival.

  • 5

    ALI and MLR showed consistent prognostic performance across all clinical subgroups, aiding in patient management and survival improvement.

Original Source(s)

Related Content